Ashique Rafique

This inventor holds 19 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Biopharmaceuticals. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashique Rafique. Retrieved from https://idiyas.com/inventor/ashique-rafique

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 12)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 9.9

ph-index = 11

Forward Citations = 496(Granted Patents)

Company Filing History:

18 out of 1,484

Regeneron Pharmaceuticals, Inc.

patents

1 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Anti-PSMA Antibodies

Bispecific Antigen-Binding Molecules

High Affinity Antibodies

IL-6 Receptor

NPR1 Agonists

Rheumatoid Arthritis

Vantigen Binding Proteins

Nucleic Acids

Human Antibodies

IL-4 Receptor

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12344677 - Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof (2025-07-01),

2. 12325752 - Immunoglobulin proteins that bind to NPR1 agonists (2025-06-10),

3. 11370843 - High affinity antibodies to human IL-6 receptor (2022-06-28),

4. 11155633 - Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof (2021-10-26),

5. 10787522 - Vantigen binding proteins exhibiting distinct binding characteristics (2020-09-29),

6. 10584173 - Nucleic acids encoding high affinity antibodies to human IL-6 receptor (2020-03-10),

7. 10179819 - Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof (2019-01-15),

8. 9884916 - High affinity antibodies to human IL-6 receptor (2018-02-06),

9. 9308256 - Method of treating rheumatoid arthritis with an anti-IL-6R antibody (2016-04-12),

10. 8568721 - Method of treating rheumatoid arthritis with an anti-IL-6R antibody (2013-10-29),

11. 8338135 - High affinity human antibodies to human IL-4 receptor (2012-12-25),

12. 8192741 - Method of treating rheumatoid arthritis with an anti-IL-6R antibody (2012-06-05),

13. 8183014 - High affinity antibodies to human IL-6 receptor (2012-05-22),

14. 8092802 - High affinity human antibodies to human IL-4 receptor (2012-01-10),

15. 8080248 - Method of treating rheumatoid arthritis with an IL-6R antibody (2011-12-20),

Title: The Innovative Journey of Ashique Rafique

Introduction: Ashique Rafique, a talented inventor hailing from Yonkers, NY, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Ashique Rafique holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing his commitment to creating a sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Ashique Rafique has led numerous successful projects that have revolutionized industries such as healthcare, transportation, and communication.

Collaborations: Throughout his career, Ashique Rafique has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work in diverse teams has been instrumental in the success of his projects.

Conclusion: Ashique Rafique's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His work continues to inspire future generations to push the boundaries of what is possible in the realm of technology.

Profile summary based on public USPTO records.